Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1988Antimicrobial Agents and ChemotherapyOpen Access

Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMichael KreskenFederal Office for Information SecurityBWB. WiedemannGoethe University Frankfurt

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kresken et al. (1988) studied this question.

synapsesocial.com/papers/6a70eed58031ec7bb1dcac31https://doi.org/10.1128/aac.32.8.1285
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations1984 · 89 citations
  2. 2The frequency of in-vitro resistance development to fluoroquinolones and the use of a murine pyelonephritis model to demonstrate selection of resistance in vivo1987 · 42 citations
  3. 3Comparative Evaluation of Recently Developed Quinolone Compounds – with a Note on the Frequency of Resistant Mutants2009 · 75 citations
  4. 4A Critical Evaluation of Nalidixic Acid in Urinary-Tract Infections1966 · 143 citations
  5. 5Identification of a Nondeletion Defect in α-Thalassemia1977 · 193 citations